Wafik S. El-Deiry, Director of Legorreta Cancer Center at Brown University and Chair of the WIN Consortium in Cancer Personalized Medicine, shared a post on LinkedIn:
“Cancer does not discriminate or take sides and the research advances that are made benefit everyone. In my own career support from the National Cancer Institute (NCI) led to discoveries and new cancer treatments including a drug we discovered that was eventually approved by the FDA in the summer of 2025 to treat aggressive brain tumors.
Other government support has led to many advances in cancer screening, prevention and precision oncology treatment. The National Institutes of Health /NCI support has become severely reduced where many labs including the El-Deiry Lab at Legorreta Cancer Center have been struggling with each passing day to keep making discoveries and to keep supporting the next generation of scientists whose work brings hope for a world with less suffering from cancer. Foundations and pharma will not fill the void as the academic science ecosystem has been in crisis.
In the last couple of days I had the honor of speaking with US Congressman Gabe Amo in Rhode Island where I work and Representative Dan Meuser in Pennsylvania where I have permanent residence about the importance of supporting biomedical research and how critical government investments are for the US to be #1 in the world.
It is very important to find a path for our government to restore support consistent with what has been done going back to the 1930’s.
It was a real honor to be invited to attend an event where President Trump spoke this evening in Pennsylvania. I would urge the administration to invest in the scientific talent and technology that have made American medicine and cancer care the envy of the world. Not doing so is already leading to a decline where other countries are jumping in to surpass the US.”
More posts featuring Wafik S. El-Deiry on OncoDaily.
